NASDAQ · Healthcare · Biotechnology
EyePoint Pharmaceuticals, Inc.
EYPT
EyePoint Pharmaceuticals, Inc. CEO Jay S. Duker · Market cap $446.0M.
$5.32
-0.08 · -1.48%
52w hi $19.1152w lo $3.95
Off 52w high 71.4%
59
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $20.67
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 18 | Karen L. Zaderej | Buy | 10,600 | $4.93 | +$52K | 59 | |
| May 19 | Karen L. Zaderej | Buy | 5,000 | $5.99 | +$30K | 37 | |
| May 16 | Karen L. Zaderej | Buy | 5,000 | $5.81 | +$29K | 37 | |
| May 15 | Karen L. Zaderej | Buy | 5,000 | $5.47 | +$27K | 37 | |
| May 14 | Karen L. Zaderej | Buy | 5,000 | $5.42 | +$27K | 55 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug